This report presents evidence for enteric bacterial adaptation to genetically controlled environmental factors in the individual human host. Human feces contains bacterial enzymes that degrade water-soluble A, B, and H antigens, and both the presence and the specificity of ABH blood group antigens in human gut mucous secretions are genetically determined for each individual. In this study, partially purified fecal blood group antigendegrading enzymes from 31 subjects of known blood group and secretor status were obtained and their relative specificity for A, B, and H antigen was measured.
INTRODUCTION 37 yr ago Schiff and his coworkers discovered enzymes in human feces and saliva that degraded water-soluble blood group substances (1) (2) (3) (4) (5) . The bacterial origin of fecal blood group-degrading (BGD) enzymes was disputed and not established (2, 6, 7) despite evidence that unidentified oral bacteria produced BGD enzymes in saliva (6, 8, 9) . The significance of fecal BGD enzyme activity to the host and to the resident enteric flora was not pursued.
I have reinvestigated fecal BGD enzymes to explore their significance in the degradation of gastrointestinal mucins and in the host-enteric flora ecosystem (10, 11) . Evidence was obtained that BGD enzymes are synthesized by intestinal bacteria and not by gastrointestinal tissues (11) . Since the capacity to secrete water-soluble ABH antigens in gastrointestinal mucous secretions and the blood group specificity of the antigens secreted are genetically determined characteristics of each human host, it seemed possible that intestinal microorganisms might adapt to their host environment by synthesizing BGD enzymes which preferentially degraded the specific blood group antigens secreted by their host. The present study was 
METHODS
Subjects. Stools were obtained from 21 healthy biomedical colleagues and from 10 patients hospitalized on the Orthopedic Service for elective operative procedures. None had historical, physical, or laboratory evidence of active gastrointestinal disease, acute disease involving other organ systems, or had recently ingested antibiotics. All subjects were eating their usual diet or a standard hospital diet at the time of collection. Their ages ranged from 24 to 68 yr. Seven were females. Neither age, race, nor sex of these adults appeared to influence the results.
Each subject's blood type was determined by the slide method using commercial human immune anti-A and anti-B typing sera. For determining blood group secretor status fresh saliva from each subject was heated at 1000C for 10 min and centrifuged. The lyophilized preparations were stored over Drierite in a desiccator at room temperature and were assayed within 2 wk. BGD enzyme activity in these preparations appears to be stable. Essentially identical degradation rates were found in two lyophilized preparations when these were reassayed after storage for 16 and 23 months respectively.
Blood group antigen substrates. Saliva from one blood group A secretor, saliva from one blood group B secretor, and gastric juice from two group 0 secretors were employed as A, B, and H antigen substrates. The salivas were heated at 100'C for 10 min and centrifuged at 700 g for 10 min. The supernatant fluid was dialyzed against four 2-liter volumes of distilled water at 40C and was lyophilized. The gastric juice was centrifuged, dialyzed, and lyophilized in the same manner.
Measurements of blood group-degrading enzyme activity. BGD enzyme activity was measured by the decrease in the titer of antigen substrate during incubation with enzyme preparation. For the assays the lyophilized antigen substrates and lyophilized enzyme preparations were dissolved separately in 0.02 M phosphate buffer, pH 6.4, containing 0.01 M MgCl2. The final concentration of A or B antigen substrate in each incubation mixture was 0.5 mg/ml and that of H antigen substrate was 1 mg/ml. The final enzyme concentration in each incubation mixture, previously selected by preliminary testing to produce significant degradation of the subject's blood group phenotype antigen after the first hour of incubation, varied from 0.06 mg/ml to 12.5 mg/ml and for most enzyme preparations was 0.5 mg/ml. The enzyme solution was added to separate tubes containing A, B, or H antigen substrate, and the mixtures were incubated at 370C for 6 hr. Aliquots were removed from each tube immediately after mixing and at various times thereafter including 1, 2, and 6 hr. BGD enzyme activity was stopped by placing each aliquot in a boiling water bath for 10 min, and the titer of antigen substrate remaining in each aliquot was then determined. The titer of antigen incubated without enzyme does not change under these conditions. Specificity of BGD activity in each preparation was evaluated by comparing the rates of degradation of A, B, and H antigen during incubation.
Hemagglutination inhibition measurements of antigen titers. The blood group antigen titer in each aliquot of the incubation mixtures was determined by the macroscopic he- During the early phase of incubation with most BGD enzyme preparations, the exponential value, n, of the antigen titer decreased at a constant rate (Fig. 1 ). Under these incubation conditions, the rate of antigen degradation, Anl per unit time, may be used as a measure of enzyme activity and is proportional to enzyme concentration in the incubation mixture (Fig. 2) . cretor. When a mixed culture of human fecal bacteria is incubated anaerobically, BGD enzyme activity can be consistently demonstrated in the cell-free culture medium after 24 hr of incubation. Furthermore, the BGD enzymes in the culture medium show specificity for the host's blood group phenotype antigen similar to that found in his stools. This is illustrated in Fig. 9 where the BGD enzymes in the control culture containing thioglycollate broth and glucose inoculated with feces from a blood group B secretor degrade B antigen more rapidly than A or H antigen. BGD enzymes in the cultures are clearly produced during bacterial growth and are not introduced with the fecal inoculum: no BGD enzyme activity is detectable immediately after inoculation, the specific activity of BGD enzyme increases during bacterial growth (11) , and the capacity to produce BGD enzymes can generally be demonstrated in subcultures made at 24 hr. When compared with the BGD enzyme activities produced in the control culture, there was a definite increase in A antigen-degrading activity in the culture containing A antigen (Fig. 9) . There was essentially no difference in the rate of B or H antigen degradation, indicating that the effect of A antigen was the preferential adaptation of A-degrading enzyme activity. This relatively specific in vitro adaptation of A-degrading enzyme by fecal bacteria grown in the presence of HGMI A antigen was confirmed in other experiments. However. the specificity of enzyme adaptation depended upon the concentration of HGM A antigen in the medium. At concentrations less than 0.2 mg/ml, the HGM failed to stimulate production of A-degrading activity. At a concentration of 0.2 mg/ml only A-degrading activity was 670 L. C. Hoskins INCUBATION TIME, HR increased, whereas in cultures containing 10 mg/ml of HGM the A-, B-, and H-degrading enzyme activities were all increased over their activities in control cultures. (21) .
DISCUSSION
It appears likely that the relative specificity of fecal BGD enzymes from ABO secretors for their blood group phenotype antigen and H antigen represents bacterial adaptation of blood group-degrading enzymes to the antigens in their host's gut mucous secretions. This conclusion is strengthened by the in vitro fecal culture experiment which demonstrated enhanced A antigen-degrading activity in the culture medium containing A antigen. Howe, MacLennan, Mandl, and Kabat (22) demonstrated a similar adaptation of A-degrading activity by a strain of Clostridium tertium when grown in a medium containing blood group substance.
The water-soluble blood group substances that are substrates for BGD enzymes are glycoproteins closely related in composition and structure (16, 23, 24) . A, B, H, and Lea antigen specificities are determined by saccharides at the nonreducing end of oligosaccharide side chains covalently linked to a polypeptide core via serine and threonine residues. A antigen specificity is conferred by a-N-acetyl-D-galactosaminoyl terminal glycosides, B specificity by a-D-galactosyl terminal glycosides, and H and Lea specificities by unsubstituted a-L-fucopyranosyl glycosides. The action of BGD enzymes obtained from several microorganisms is known (25) (26) (27) (28) (29) (30) . With the exception of the deacetylase from Clostridium tertium described by Marcus, Kabat, and Schiffman which hydrolyzes the acetyl group from the terminal a-N-acetyl-D-galactosaminoyl antigenic determinant of A substance (29) , these are glycosidases which cleave the antigenic determinant saccharides from oligosaccharide side chains of blood group substances.
Blood group-degrading enzyme activity is found in saliva (6, 8, 9) and in the contents of the terminal ileum and colon (20) . Although strains of several species of microorganisms, notably those of the genus Clostridium, produce BGD enzymes (25) (26) (27) (28) (29) (30) , it is not known whether these or other species are responsible for BGD enzymes in the majority of human stools.
There is evidence that intestinal bacteria degrade gastrointestinal mucins and utilize the constituents of mucus, especially the carbohydrate moieties (10, 31 
